Overview

Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy

Status:
RECRUITING
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
A study comparing efficacy of olanzapine versus placebo to prevent nausea and vomiting from moderate emetic risk chemotherapy
Phase:
PHASE3
Details
Lead Sponsor:
Mahidol University
Treatments:
Olanzapine